Gould P. Elisha's most recent trade in Corvus Pharmaceuticals Inc was a trade of 15,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 13, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Corvus Pharmaceuticals Inc | Elisha P. Gould | Director, Ten Percent Owner | 13 Jun 2024 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | ||
| Corvus Pharmaceuticals Inc | Gould P. Elisha | Director, Ten Percent Owner | 06 Dec 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | ||
| Corvus Pharmaceuticals Inc | Elisha P. Gould | Director, Ten Percent Owner | 15 Jun 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | ||
| Corvus Pharmaceuticals Inc | Elisha P. Gould | Director, Ten Percent Owner | 11 Aug 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | ||
| Corvus Pharmaceuticals Inc | Elisha P. Gould | Director, Ten Percent Owner | 15 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | ||
| Corvus Pharmaceuticals Inc | Elisha P. Gould | Director, Ten Percent Owner | 09 Sep 2021 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | ||
| Icosavax Inc | Elisha P. Gould | Director | 02 Aug 2021 | 3,631,066 | 0 | - | - | Series A-1 Preferred Stock | ||
| Icosavax Inc | Elisha P. Gould | Director | 02 Aug 2021 | 3,509,939 | 0 | - | - | Series A-1 Preferred Stock | ||
| Icosavax Inc | Elisha P. Gould | Director | 02 Aug 2021 | 2,013,269 | 0 | - | - | Series A-1 Preferred Stock | ||
| Icosavax Inc | Elisha P. Gould | Director | 02 Aug 2021 | 1,348,119 | 0 | - | - | Series A-1 Preferred Stock | ||
| Icosavax Inc | Elisha P. Gould | Director | 02 Aug 2021 | 1,042,120 | 0 | - | - | Series A-1 Preferred Stock | ||
| Icosavax Inc | Elisha P. Gould | Director | 02 Aug 2021 | 948,188 | 948,188 | - | 0 | Common Stock | ||
| Icosavax Inc | Elisha P. Gould | Director | 02 Aug 2021 | 935,985 | 0 | - | - | Series A-1 Preferred Stock | ||
| Icosavax Inc | Elisha P. Gould | Director | 02 Aug 2021 | 916,558 | 916,558 | - | 0 | Common Stock | ||
| Icosavax Inc | Elisha P. Gould | Director | 02 Aug 2021 | 525,729 | 525,729 | - | 0 | Common Stock | ||
| Icosavax Inc | Elisha P. Gould | Director | 02 Aug 2021 | 352,037 | 352,037 | - | 0 | Common Stock | ||
| Icosavax Inc | Elisha P. Gould | Director | 02 Aug 2021 | 309,321 | 0 | - | - | Series B-1 Preferred Stock | ||
| Icosavax Inc | Elisha P. Gould | Director | 02 Aug 2021 | 299,003 | 0 | - | - | Series B-1 Preferred Stock | ||
| Icosavax Inc | Elisha P. Gould | Director | 02 Aug 2021 | 272,131 | 272,131 | - | 0 | Common Stock | ||
| Icosavax Inc | Elisha P. Gould | Director | 02 Aug 2021 | 244,415 | 244,415 | - | 0 | Common Stock | ||
| Icosavax Inc | Elisha P. Gould | Director | 02 Aug 2021 | 171,505 | 0 | - | - | Series B-1 Preferred Stock | ||
| Icosavax Inc | Elisha P. Gould | Director | 02 Aug 2021 | 114,843 | 0 | - | - | Series B-1 Preferred Stock | ||
| Icosavax Inc | Elisha P. Gould | Director | 02 Aug 2021 | 88,775 | 0 | - | - | Series B-1 Preferred Stock | ||
| Icosavax Inc | Elisha P. Gould | Director | 02 Aug 2021 | 79,734 | 0 | - | - | Series B-1 Preferred Stock | ||
| Icosavax Inc | Elisha P. Gould | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 02 Aug 2021 | 47,981 | 996,169 | - | 15 | 719,715 | Common Stock |
| Icosavax Inc | Elisha P. Gould | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 02 Aug 2021 | 46,381 | 962,939 | - | 15 | 695,715 | Common Stock |
| Icosavax Inc | Elisha P. Gould | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 02 Aug 2021 | 26,604 | 552,333 | - | 15 | 399,060 | Common Stock |
| Icosavax Inc | Elisha P. Gould | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 02 Aug 2021 | 12,368 | 256,783 | - | 15 | 185,520 | Common Stock |